Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
72°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Galera Therapeutics
Galera Announces Board Approval of Complete Liquidation and Dissolution
August 14, 2024
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates
May 13, 2024
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Adopts Limited Duration Stockholder Rights Agreement
May 03, 2024
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
March 28, 2024
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
November 14, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Announces Receipt of Type A Meeting Minutes and Strategic Update
October 31, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem
September 18, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Reports Second Quarter 2023 Financial Results and Recent Corporate Updates
August 14, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese
August 09, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Presents Additional Chronic Kidney Disease Data from ROMAN Trial at 2023 ASCO Annual Meeting
June 05, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer
May 18, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Reports First Quarter 2023 Financial Results and Recent Corporate Updates
May 11, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 04, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Expands Commercial Leadership Team
May 01, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera to Present One-Year Reductions in Cisplatin-Related Chronic Kidney Disease Data from ROMAN Trial at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
April 26, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Announces Presentation of Supplemental Analysis of Phase 3 ROMAN Trial at European Congress on Head and Neck Oncology
March 10, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates
March 08, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Therapeutics Announces Pricing of Registered Direct Offering of $30 Million of Common Stock and Warrants
February 15, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Announces FDA Acceptance and Priority Review of Avasopasem NDA for Radiotherapy-Induced Severe Oral Mucositis
February 15, 2023
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis
December 12, 2022
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera to Present at Piper Sandler Annual Healthcare Conference
November 22, 2022
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
November 09, 2022
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
October 26, 2022
From
Galera Therapeutics
Via
GlobeNewswire
Tickers
GRTX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.